These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31776283)

  • 21. Hepatic expression levels of interferons and interferon-stimulated genes in patients with chronic hepatitis C: A phenotype-genotype correlation study.
    Noureddin M; Rotman Y; Zhang F; Park H; Rehermann B; Thomas E; Liang TJ
    Genes Immun; 2015; 16(5):321-9. PubMed ID: 26020282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IFN-λ3, not IFN-λ4, likely mediates IFNL3-IFNL4 haplotype-dependent hepatic inflammation and fibrosis.
    Eslam M; McLeod D; Kelaeng KS; Mangia A; Berg T; Thabet K; Irving WL; Dore GJ; Sheridan D; Grønbæk H; Abate ML; Hartmann R; Bugianesi E; Spengler U; Rojas A; Booth DR; Weltman M; Mollison L; Cheng W; Riordan S; Mahajan H; Fischer J; Nattermann J; Douglas MW; Liddle C; Powell E; Romero-Gomez M; George J;
    Nat Genet; 2017 May; 49(5):795-800. PubMed ID: 28394349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
    Stättermayer AF; Strassl R; Maieron A; Rutter K; Stauber R; Strasser M; Beinhardt S; Datz C; Scherzer TM; Steindl-Munda P; Gschwantler M; Trauner M; Hofer H; Ferenci P
    Aliment Pharmacol Ther; 2014 Jan; 39(1):104-11. PubMed ID: 24205831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.
    Konishi H; Motomura T; Matsumoto Y; Harimoto N; Ikegami T; Yoshizumi T; Soejima Y; Shirabe K; Fukuhara T; Maehara Y
    J Viral Hepat; 2014 Jun; 21(6):397-404. PubMed ID: 24750545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationships between IFNL4 genotype, intrahepatic interferon-stimulated gene expression and interferon treatment response differs in HCV-1 compared with HCV-3.
    Holmes JA; Congiu M; Bonanzinga S; Sandhu MK; Kia YH; Bell SJ; Nguyen T; Iser DM; Visvanathan K; Sievert W; Bowden DS; Desmond PV; Thompson AJ
    Aliment Pharmacol Ther; 2015 Aug; 42(3):296-306. PubMed ID: 26032235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What Have We Learned from Studies of IFN-λ Variants and Hepatitis C Virus Infection?
    O'Brien TR; Jackson SS
    J Interferon Cytokine Res; 2019 Oct; 39(10):618-626. PubMed ID: 31161939
    [TBL] [Abstract][Full Text] [Related]  

  • 27.
    Baker FS; Wang J; Florez-Vargas O; Brand NR; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Chagaluka G; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Prokunina-Olsson L; Mbulaiteye SM
    J Interferon Cytokine Res; 2023 Sep; 43(9):394-402. PubMed ID: 37366802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic Variation at IFNL4 Influences Extrahepatic Interferon-Stimulated Gene Expression in Chronic HCV Patients.
    Rosenberg BR; Freije CA; Imanaka N; Chen ST; Eitson JL; Caron R; Uhl SA; Zeremski M; Talal A; Jacobson IM; Rice CM; Schoggins JW
    J Infect Dis; 2018 Jan; 217(4):650-655. PubMed ID: 29165633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response to antiviral treatment.
    Riva E; Scagnolari C; Turriziani O; Antonelli G
    Clin Microbiol Infect; 2014 Dec; 20(12):1237-45. PubMed ID: 25273834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels.
    Jouvin-Marche E; Macek Jílková Z; Thelu MA; Marche H; Fugier E; Van Campenhout N; Hoang XS; Marlu A; Sturm N; Callanan M; Leroy V; Zarski JP; Marche PN
    J Infect Dis; 2014 Jun; 209(12):1907-15. PubMed ID: 24415789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
    Amanzada A; Reinhardt L; Fey D; Zeisberg EM; Mihm S
    PLoS One; 2015; 10(11):e0143783. PubMed ID: 26606750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
    Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous levels of mRNA for IFNs and IFN-related genes in hepatic biopsies of chronic HCV-infected and non-alcoholic steatohepatitis patients.
    Abbate I; Romano M; Longo R; Cappiello G; Lo Iacono O; Di Marco V; Paparella C; Spano A; Capobianchi MR
    J Med Virol; 2003 Aug; 70(4):581-7. PubMed ID: 12794720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
    Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
    Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interleukin-29 functions cooperatively with interferon to induce antiviral gene expression and inhibit hepatitis C virus replication.
    Pagliaccetti NE; Eduardo R; Kleinstein SH; Mu XJ; Bandi P; Robek MD
    J Biol Chem; 2008 Oct; 283(44):30079-89. PubMed ID: 18757365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
    Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
    Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children.
    Samayoa-Reyes G; Jackson C; Ogolla S; Sabourin K; Obajemu A; Dent AE; Prokunina-Olsson L; Rochford R
    Malar J; 2021 Apr; 20(1):196. PubMed ID: 33882912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender-dependent multiple cross-phenotype association of interferon lambda genetic variants with peripheral blood profiles in healthy individuals.
    Roy DG; Singh L; Chaturvedi HK; Chinnaswamy S
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2292. PubMed ID: 37795763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virus.
    Diegelmann J; Beigel F; Zitzmann K; Kaul A; Göke B; Auernhammer CJ; Bartenschlager R; Diepolder HM; Brand S
    PLoS One; 2010 Dec; 5(12):e15200. PubMed ID: 21170333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
    Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
    J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.